Total Funding
2
47
Total FundingVenture - Series Unknown raised
Growth Score
-7 pts
Heat Score
-26 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
49881
Blade Therapeutics is a discovery stage drug development company.
Ravi Rajagopalan: Executive Director, Drug Discovery BiologyPast Role: InterMune, Director, Discovery Biology- Felix Karim: EVP, Business Development
About the Company
Blade Therapeutics is a discovery stage drug development company. Their mission is to create antifibrotic treatment strategies that address a wide variety of congenital and acquired diseases of fibrosis. Their leadership team has extensive experience at developing drugs that treat fibrotic disorders. They are also partnering with international
experts in order to identify and in-license cutting-edge technologies to build a robust pipeline of antifibrotic compounds.
Women Led
